Biology Reference
In-Depth Information
CBD (2004) Decision VI/7. Identification, monitoring, indicators and assessments. Guidelines
for incorporating biodiversity related issues into environmental-impact-assessment legislation
or processes and in strategic impact assessment. Secretarial of the Convention on Biological
Diversity, Montreal
CBD (2006) CBD Technical Series No. 26 - Biodiversity in impact assessment. Background
document to CBD Decision VIII/28: Voluntary guidelines on biodiversity-inclusive impact
assessment. Secretarial of the Convention on Biological Diversity, Montreal
CEC (2004) Maize & Biodiversity. The effects of transgenic maize in Mexico - Key findings and
recommendations. Secretariat of the Commission for Environmental Cooperation, Quebec
Chaker A, El-Fad K, Chamas L, Hatjian B (2006) A review of strategic environmental assessment
in 12 selected countries. Environ Impact Assess Rev 26:15-56
Chipman A (2010) Fears over Europe's GM crop plan. Nature 466:542-543
COGEM (2009) Socio-economic aspects of GMOs. Building blocks for an EU sustainability
assessment of genetically modified crops. Commissie Genetische Modificatie, Bilthoven
Cohen SN (1975) The manipulation of genes. Sci Am 233:25-32
Cohen SN (1977) Recombinant DNA: fact and fiction. Science 195:654-657
Commandeur P, Joly PB, Levidow L, Tappeser B, Terragni F (1996) Public debate and regulation
of biotechnology in Europe. Biotech Dev Monit 26:2-9
Committee on Improving Risk Analysis Approaches Used by the U.S. EPA (2009) Science and
decisions: advancing risk assessment. National Research Council, Washington, DC
de Greef W (2004) The Cartagena Protocol and the future of agbiotech. Nat Biotechnol 22:811-812
Deutscher Bundestag (1987) Chancen und Risiken der Gentechnologie. Deutscher Bundes-
tag, Bonn
Devos, Y, Reheul D, Dewaele D, van Speybroeck, L (2006) The interplay between societal con-
cerns and the regulatory frame on GM crops in the European Union. Environ Biosaf Res
5:127-149
EFSA (2010a) Guidance on the environmental risk assessment of genetically modified plants.
EFSA J 8(11):1879 doi:10.2903/j.efsa.2010.1879
EFSA (2010b) Scientific Opinion on the assessment of potential impacts of genetically modified
plants on non-target organisms. EFSA J 8(11):1879 doi:10.2903/j.efsa.2010.1877
EPA (2001) Bt cotton confirmatory data and terms and conditions of the amendment. EPA,
Washington, DC
European Commission (2010) New policy for genetically modified organisms (GMO) cultivation.
European Commission, Brussels
Falck-Zepeda JB (2009) Socio-economic considerations, Article 26.1 of the Cartagena protocol on
biosafety: What are the issues and what is at stake? AgBioForum 12(1):90-107
Food and Drug Administration (1992) Statement of policy & guidance to industry: foods derived
from new plant varieties. Food and Drug Administration, Silver Spring, MD
Garcia-Alonso M, Jakobs E, Raybould A, Nickson TE, Sowig P, Willekens H, van der Kouwe P,
Layton R, Amijee F, Fuentes AM (2006) A tiered system for assessing the risk of genetically
modified plants to non-target organisms. Environ Biosaf Res 5:57-65
Gibbons M (1999) Science's new social contract with society. Nature 402(Suppl):6761
Glemnitz M, Wurbs A, Roth R (2011) Derivation of regional crop sequences as an indicator
for potential GMO dispersal on large spatial scales. Ecological Indicators 11(4):964-973.
doi:10.1016/j.ecolind.2009.03.005
Gnansounou E (2011) Assessing the sustainability of biofuels: a logic-based model. Energy 36:
2089-2096
Goodell RS (1979) Public involvement in the DNA controversy: the case of Cambridge, Mas-
sachusetts. Sci Technol Human Values 4:36-43
Goodland R (2005) Strategic environmental assessment and the World Bank group. Inter J Sustain
Dev World Ecol 12:1-11
Gupta A (1999) Framing “biosafety” in an international context: the biosafety protocol negotia-
tions. Harvard University, Cambridge
Search WWH ::
Custom Search